ACAD
ACADIA PHARMACEUTICALS INC
Key Financials
Net Income
$391.0M
↑ 72.7%
Gross Profit
$684.8M
↑ 221.3%
Revenue
$1.1B
↑ 11.9%
Operating Income
$104.8M
↓ 54.6%
EPS (Diluted)
$2.30
↑ 69.1%
Total Assets
$1.6B
↑ 31.7%
Total Liabilities
$336.8M
↓ 26.0%
Cash & Equivalents
$177.7M
↓ 44.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ACAD |
| Company Name | ACADIA PHARMACEUTICALS INC |
| CIK | 1070494 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 858-558-2871 |